Early research (Phase 1)Study completedNCT00951873
What this trial is testing
A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers
Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B+1 more
Novo Nordisk A/S 38